CLS Celestica Inc

Celestica is an electronics manufacturing services company producing complex assemblies and systems for communications, enterprise, aerospace, defense, and healthcare customers. Sector: Technology.

Celestica Inc (CLS) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 31.74%, WACC is 12.64%, and the economic spread is 19.10%. On balance, the economic spread is positive and meaningful, suggesting the company are building rather than eroding intrinsic value. Supporting metrics show ROE at 42.05% and ROA at 11.52%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

From a market pricing perspective, trailing P/E of 41.01, forward P/E of 32.91, PEG of 1.16. A modest gap between trailing and forward multiples implies the market is pricing incremental earnings improvement rather than a step-change in profitability. The PEG ratio suggests the market may be underpricing the company's growth trajectory relative to its current multiple. The company carries an aggregate current ratio of 1.44, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 12.05%, operating margin at 8.61%, and free cash flow margin at 3.70%. Thin gross margins leave limited room for operational leverage — cost discipline at every layer becomes critical. The company's operating margins leave limited room between gross profit and operating earnings — a sign of cost pressure. FCF margins are negligible or negative, indicating businesses where cash generation has not yet caught up with operational or growth spending. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of 8.05%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 43.57% suggesting the company is collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 24.6% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Putting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.